Company: PETVW
Filing Date: 2025-07-10
Form Type: 10-K
Source: 0001641172-25-018617
Chunk: 845

Company: PetVivo Holdings, Inc.
Filing Date: 2025-07-10
Form: 10-K
Item: Item 7
Chunk 845
---
5, reported ownership as A.L. Sarroff Fund, LLC,.
    Mr. Sarroff’s directly owns 5,620,002 common shares and 4,638,696 warrants as follows: The Warrants are exercisable on the
    following schedule: $1,166,000.00 exercisable as of August 4, 2026, 111,000 exercisable as of December 6, 2026, and 861,696 as of
    April 29, 2027 and 2,500,000 exercisable as of July 9, 2027.

    (14)
    As
    reported in Mr. Cruden’s Schedule 13G filed with the SEC on March 31, 2025, Mr. Cruden directly owns 2,413,470 common shares.

ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

The
following is a summary of the transactions since April 1, 2020 between the Company and its executive officers, directors, nominees for
directors, principal shareholders, and related parties involving amounts in excess of $120,000 or that the Company has chosen to voluntarily
disclose.

David
Masters

Note
and Settlement Agreement

Effective
September 1, 2020, the Company entered into two debt settlement agreements with David B. Masters, a director of the Company, pursuant
to (i) an Amendment to Promissory Note (“Amendment”) which amended certain outstanding promissory notes dated September 5,
2013, February 11, 2014, and August 14, 2014 (collectively, the “Outstanding Notes”) issued by Gel-Del, the Company’s
wholly-owned subsidiary, with an aggregate amount owed of $65,700 and (ii) a Promissory Note (“Note”) having a principal
amount of $195,000, which represents accrued salary owed to Dr. Masters. The Amendment extends, for up to an additional two years and
under the same terms as originally entered into, the Outstanding Notes. The Company also entered into a Settlement and General Release
(“Settlement Agreement”) with Dr. Masters that provides for the settlement and general release of any and all past claims,
demands, damages, judgements, causes of action and liabilities that Dr. Masters may have had, may currently have or may acquire against
the Company and its subsidiaries,